Product Information

METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by Ipca Laboratories Limited, priced at $0.0352 per EA under NDC 83980001005. Its NADAC has been published 79 times since May 14, 2025.

FDA first approved this application on Jun 12, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOCLOPRAMIDE 5 MG TABLET

Metoclopramide
$0.0352per EA

Strength

5 mg/1

NDC

83980001005

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078807

FDA Approved

6/12/2008

TE Code

AB

On Market Since

1/9/2025

Pharmacological Classes

Dopamine D2 Antagonists
Dopamine-2 Receptor Antagonist

Price Statistics

The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 79 times since May 14, 2025, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0352 per EA
All-time high$0.0433 (May 14, 2025)
All-time low$0.0352 (Oct 21, 2026)
52-week high$0.0433
52-week low$0.0352
Median price$0.0424
Average price$0.0400
Largest weekly change-6.0% (Feb 18, 2026)
Weeks tracked79
Tracking sinceMay 14, 2025

Price History

1W

0.0%

1M

-1.7%

3M

-2.9%

6M

-5.1%

1Y

-17.6%

3Y

N/A

5Y

N/A

All

-18.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by Ipca Laboratories Limited, is $0.0352 per EA (NDC 83980001005), effective Nov 11, 2026.

How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 18.8%. It has been tracked across 79 weekly CMS publications since May 14, 2025.

What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?

Since May 14, 2025, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0352 (Oct 21, 2026) to a high of $0.0433 (May 14, 2025), with a median of $0.0424 per EA.

Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METOCLOPRAMIDE 5 MG TABLET?

METOCLOPRAMIDE 5 MG TABLET (NDC 83980001005) is labeled by Ipca Laboratories Limited, and CMS classifies it as a generic product.